BVT Aktienanleihe AMD 27.09.2024/ DE000VU954N1 /
24/06/2024 08:54:11 | Chg.-0.04 | Bid18:09:52 | Ask18:09:52 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
103.13EUR | -0.04% | 103.25 Bid Size: 500,000 |
103.35 Ask Size: 500,000 |
Advanced Micro Devic... | 120.00 USD | 27/09/2024 | Call |
GlobeNewswire
14:00
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
19/06
AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire
18/06
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
17/06
D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
GlobeNewswire
14/06
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
13/06
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
13/06
Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire
12/06
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
12/06
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
12/06
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire
11/06
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
10/06
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
08/06
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...